Mitotic Machinery Dysregulation in Lung Cancer: Biological Roles, Therapeutic Targeting, and Combination Strategies
admin-cespu
Bibliographic reference:
Pinto, B., Silva, J. P. N., Silva, P. M. A., Sarmento, B., Carvalho-Tavares, J., & Bousbaa, H. (2026). Mitotic Machinery Dysregulation in Lung Cancer: Biological Roles, Therapeutic Targeting, and Combination Strategies. Pharmaceutics, 18(4), 402. https://doi.org/10.3390/pharmaceutics18040402
Pinto, B., Silva, J. P. N., Silva, P. M. A., Sarmento, B., Carvalho-Tavares, J., & Bousbaa, H. (2026). Mitotic Machinery Dysregulation in Lung Cancer: Biological Roles, Therapeutic Targeting, and Combination Strategies. Pharmaceutics, 18(4), 402. https://doi.org/10.3390/pharmaceutics18040402